The continued globalization and restructuring of drug development activities demands a new approach to scientific knowledge management, and Centrus finally allows organizations to unlock silos and leverage the information for better decision-making across the value chain.
Phil Reason, Instem CEO
Centrus
- Offering an integrated global view of data from biology-related development activities ranging from lead optimization through phase I clinical, in areas such as the safety and efficacy assessment of drugs, diagnostics, biomarkers and medical devices, Centrus is highly efficient for both researchers and administrators
- Centrus is built using an easy to integrate, Service Oriented Architecture (“SOA”), and can be delivered at a client’s site or via Instem’s SaaS model from one of our secure data centers
- By having the ability to access various sources and formats of data, Centrus adds value to existing systems; collating and standardizing information and distributing the results to sponsors, regulators and partners
- Centrus allows early development information to integrate with translational science and comparative effectiveness research initiatives seeking to transfer research knowledge for improved patient outcomes
- As part of the Centrus family of products, Instem’s submit™ solution converts any source system data into SEND files. Learn more…
Links
Accessibility
Contact Us
© 2001 - 2012 Instem Group of Companies - All rights reserved